Drug Trial Radar · NCT07611214
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Last checked: Nov 20, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Apr 22, 2026
Primary completion
Mar 2, 2029
Study completion Mar 2, 2029
Sponsor
- Lead sponsor
- Aurinia Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- May 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical study is to assess the efficacy and safety of LUPKYNIS® in combination with belimumab, obinutuzumab or anifrolumab at inducing rapid renal response in patients with lupus nephritis (LN).
Conditions
- Lupus Nephritis
Interventions
LUPKYNISDrug
voclosporin
belimumab, obinutuzumab or anifrolumabBiological
BENLYSTA (belimumab), GAZYVA (obinutuzumab) or SAPHNELO (anifrolumab)
mycophenolic acid analog (MPAA)Drug
CELLCEPT (mycophenolate mofetil \[MMF\]) or MYFORTIC (mycophenolic acid \[MPA\])
corticosteroidDrug
prednisone (or equivalent)
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the efficacy of LUPKYNIS in combination with belimumab, obinutuzumab or anifrolumab at inducing rapid renal response: Proportion of patients with complete renal response at 24 weeksTime frame: 24 weeks
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Purushotham & Akther Kotha MD, Inc.
La Mesa, California · Recruiting
Valerius Medical Group & Research Center of Greater Long Beach, Inc.
Los Alamitos, California · Recruiting
Western Nephrology & Metabolic Bone Disease, PC
Arvada, Colorado · Recruiting
Swati Shah MD Rheumatology, LLC
Jacksonville, Florida · Recruiting
Vida Clinical Research
Kissimmee, Florida · Recruiting
Life Clinical Trials
Margate, Florida · Recruiting
CTR Oakwater
Orlando, Florida · Recruiting
Parris and Associates Rheumatology
Lawrenceville, Georgia · Recruiting
Accurate Clinical Research, Inc.
Lake Charles, Louisiana · Recruiting
Arthritis and Rheumatism Associates
Rockville, Maryland · Recruiting
Kansas City Physician Partners
Kansas City, Missouri · Recruiting
University of Nevada Las Vegas
Las Vegas, Nevada · Recruiting
Sahni Rheumatology & Therapy
West Long Branch, New Jersey · Recruiting
Buffalo Rheumatology and Medicine, PLLC
Orchard Park, New York · Recruiting
Arthritis and Osteoporosis Consultants of the Carolinas
Charlotte, North Carolina · Recruiting
Joint and Muscle Research Institute
Charlotte, North Carolina · Recruiting
Rheumatic Disease Associates, Ltd.
Willow Grove, Pennsylvania · Recruiting
Dunes Clinical Research
Dakota Dunes, South Dakota · Recruiting
West Tennessee Research Institute
Jackson, Tennessee · Recruiting
Novel Research LLC
Bellaire, Texas · Recruiting
Liberty Research Center
Dallas, Texas · Recruiting
Texas Arthritis Center
El Paso, Texas · Recruiting
Integrative Rheumatology of South Texas
Harlingen, Texas · Recruiting
Northwest Houston Arthritis Center
Houston, Texas · Recruiting
Texas Tech University Health Science Center
Lubbock, Texas · Recruiting
Texas Rheumatology Research Institute, LLC
Plano, Texas · Recruiting
Nephrology Leaders and Associates, PLLC
Van Vleck, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.